Fate and Effect of Intravenously Infused Mesenchymal Stem Cells in a Mouse Model of Hepatic Ischemia Reperfusion Injury and Resection

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Saat, T C ^a   Van Den Engel, S ^a   Bijman Lachger, W ^a   Korevaar, S S ^a   Hoogduijn, M J ^a   Ijzermans, J N M ^a   De Bruin, R W F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FATE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; IN VIVO STUDY; LIVER CELL; LIVER ISCHEMIA; LIVER REGENERATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 84959168052     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/5761487     Document Type: Article

References (45)

1. M. L. Shiffman, R. S. Brown Jr., K. M. Olthoff et al., "Living donor liver transplantation: summary of a conference at The National Institutes of Health," Liver Transplantation, vol. 8, no. 2, pp. 174-188, 2002.
2. M. Karoui, C. Penna, M. Amin-Hashem et al., "Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases," Annals of Surgery, vol. 243, no. 1, pp. 1-7, 2006.
3. S. Skullman, I. Ihse, and J. Larsson, "Influence of malnutrition on regeneration and composition of the liver in rats," Acta Chirurgica Scandinavica, vol. 156, no. 10, pp. 717-722, 1990.
4. N. A. Timchenko, "Aging and liver regeneration," Trends in Endocrinology and Metabolism, vol. 20, no. 4, pp. 171-176, 2009.
5. M. J. Schindl, D. N. Redhead, K. C. H. Fearon, O. J. Garden, and S. J. Wigmore, "The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection," Gut, vol. 54, no. 2, pp. 289-296, 2005.
6. Q. Zhou, L. Li, and J. Li, "Stem cells with decellularized liver scaffolds in liver regeneration and their potential clinical applications," Liver International, vol. 35, no. 3, pp. 687-694, 2015.
7. D. Ansari, M. Bergenfeldt, B. Tingstedt, and R. Andersson, "Multimodal management of colorectal liver metastases and the effect on regeneration and outcome after liver resection," Scandinavian Journal of Gastroenterology, vol. 47, no. 12, pp. 1460-1466, 2012.
8. M. H. Attwa and S. A. El-Etreby, "Guide for diagnosis and treatment of hepatocellular carcinoma," World Journal of Hepatology, vol. 7, no. 12, pp. 1632-1651, 2015.
9. A. Waghray, A. R. Murali, and K. N. Menon, "Hepatocellular carcinoma: from diagnosis to treatment," World Journal of Hepatology, vol. 7, no. 8, pp. 1020-1029, 2015.
10. T. Karatzas, A.-A. Neri, M.-E. Baibaki, and I. A. Dontas, "Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms," Journal of Surgical Research, vol. 191, no. 2, pp. 399-412, 2014.
11. G. Datta, B. J. Fuller, and B. R. Davidson, "Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models," World Journal of Gastroenterology, vol. 19, no. 11, pp. 1683-1698, 2013.
12. F. Dahm, P. Georgiev, and P.-A. Clavien, "Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications," American Journal of Transplantation, vol. 5, no. 11, pp. 2605-2610, 2005.
13. H. Kanazawa, Y. Fujimoto, T. Teratani et al., "Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model," PLoS ONE, vol. 6, no. 4, Article ID e19195, 2011.
14. M. Ben-Haim, S. Emre, T. M. Fishbein et al., "Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease," Liver Transplantation, vol. 7, no. 11, pp. 948-953, 2001.
15. M. J. Hoogduijn, M. Roemeling-Van Rhijn, A. U. Engela et al., "Mesenchymal stem cells induce an inflammatory response after intravenous infusion," Stem Cells and Development, vol. 22, no. 21, pp. 2825-2835, 2013.
16. J. W. Lee, X. Fang, A. Krasnodembskaya, J. P. Howard, and M. A. Matthay, "Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors," Stem Cells, vol. 29, no. 6, pp. 913-919, 2011.
17. G. Jin, G. Qiu, D. Wu et al., "Allogeneic bone marrow-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury by suppressing oxidative stress and inhibiting apoptosis in rats," International Journal of Molecular Medicine, vol. 31, no. 6, pp. 1395-1401, 2013.
18. C.-K. Sun, C.-L. Chang, Y.-C. Lin et al., "Systemic administration of autologous adipose-derived mesenchymal stem cells alleviates hepatic ischemia-reperfusion injury in rats," Critical Care Medicine, vol. 40, no. 4, pp. 1279-1290, 2012.
19. T. Seki, Y. Yokoyama, H. Nagasaki, T. Kokuryo, and M. Nagino, "Adipose tissue-derived mesenchymal stem cell transplantation promotes hepatic regeneration after hepatic ischemia-reperfusion and subsequent hepatectomy in rats," Journal of Surgical Research, vol. 178, no. 1, pp. 63-70, 2012.
20. M. Kaibori, Y. Adachi, T. Shimo et al., "Stimulation of liver regeneration after hepatectomy in mice by injection of bone marrow mesenchymal stem cells via the portal vein," Transplantation Proceedings, vol. 44, no. 4, pp. 1107-1109, 2012.
21. R. F. Saidi, B. Rajeshkumar, A. Shariftabrizi, K. Dresser, and O. Walter, "Human C1 inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration," Journal of Surgical Research, vol. 187, no. 2, pp. 660-666, 2014.
22. W. Wang, Z. Du, J. Yan et al., "Mesenchymal stem cells promote liver regeneration and prolong survival in small-for-size liver grafts: involvement of C-Jun N-terminal kinase, cyclin D1, and NF-κB," PLoS ONE, vol. 9, no.12, Article ID e112532, 2014.
23. R. F. Saidi, B. Rajeshkumar, A. Shariftabrizi et al., "Human adipose-derived mesenchymal stem cells attenuate liver ischemia-reperfusion injury and promote liver regeneration," Surgery, vol. 156, no. 5, pp. 1225-1231, 2014.
24. L. Behr, M. Hekmati, A. Lucchini et al., "Evaluation of the effect of autologous mesenchymal stem cell injection in a large-animal model of bilateral kidney ischaemia reperfusion injury," Cell Proliferation, vol. 42, no. 3, pp. 284-297, 2009.
25. L. Behr, M. Hekmati, G. Fromont et al., "Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postischemic kidney," Nephron Physiology, vol. 107, no. 3, pp. p65-p76, 2007.
26. M. Verweij, T. M. Van Ginhoven, J. R. Mitchell et al., "Preoperative fasting protects mice against hepatic ischemia/reperfusion injury: mechanisms and effects on liver regeneration," Liver Transplantation, vol. 17, no. 6, pp. 695-704, 2011.
27. A. Zimmermann, "Regulation of liver regeneration," Nephrology Dialysis Transplantation, vol. 19, no. 4, supplement 4, pp. iv6-iv10, 2004.
28. X.-B. Chen and M.-Q. Xu, "Primary graft dysfunction after liver transplantation," Hepatobiliary and Pancreatic Diseases International, vol. 13, no. 2, pp. 125-137, 2014.
29. M. Morigi, M. Introna, B. Imbertietal.,"Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice," Stem Cells, vol. 26, no. 8, pp. 2075-2082, 2008.
30. H. Aurich, M. Sgodda, P. Kaltwaßer et al., "Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo," Gut, vol. 58, no. 4, pp. 570-581, 2009.
31. M. A. González, E. Gonzalez-Rey, L. Rico, D. Büscher, and M. Delgado, "Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses," Gastroenterology, vol. 136, no. 3, pp. 978-989, 2009.
32. M. Elias-Miró, M. B. Jiménez-Castro, J. Rodés, and C. Peralta, "Current knowledge on oxidative stress in hepatic ischemia/reperfusion," Free Radical Research, vol. 47, no. 8, pp. 555-568, 2013.
33. R. F. van Golen, M. J. Reiniers, P. B. Olthof, T. M. van Gulik, and M. Heger, "Sterile inflammation in hepatic ischemia/reperfusion injury: present concepts and potential therapeutics," Journal of Gastroenterology and Hepatology, vol. 28, no. 3, pp. 394-400, 2013.
34. W. A. Border and N. A. Noble, "TGF-β in kidney fibrosis: a target for gene therapy," Kidney International, vol. 51, no. 5, pp. 1388-1396, 1997.
35. E. P. Böttinger and M. Bitzer, "TGF-β signaling in renal disease," Journal of the American Society of Nephrology, vol. 13, no. 10, pp. 2600-2610, 2002.
36. H. W. Schnaper, T. Hayashida, S. C. Hubchak, and A.-C. Poncelet, "TGF-β signal transduction and mesangial cell fibrogenesis," The American Journal of Physiology - Renal Physiology, vol. 284, no. 2, pp. F243-F252, 2003.
37. Y. Yu, L. Lu, X. Qian et al., "Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats," Stem Cells and Development, vol. 19, no. 6, pp. 903-914, 2010.
38. E. Eggenhofer, V. Benseler, A. Kroemer et al., "Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion," Frontiers in Immunology, vol. 3, article 297, Article ID Article 297, 2012.
39. I. M. Barbash, P. Chouraqui, J. Baron et al., "Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution," Circulation, vol. 108, no. 7, pp. 863-868, 2003.
40. A. C. M. Assis, J. L. Carvalho, B. A. Jacoby et al., "Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart," Cell Transplantation, vol. 19, no. 2, pp.219-230, 2010.
41. U. M. Fischer, M. T. Harting, F. Jimenez et al., "Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect," Stem Cells and Development, vol. 18, no. 5, pp. 683-691, 2009.
42. A. Chapel, J. M. Bertho, M. Bensidhoum et al., "Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome," Journal of Gene Medicine, vol. 5, no. 12, pp. 1028-1038, 2003.
43. M. Nowacki, Ł. Nazarewski, M. Pokrywczyńska et al., "Long-term influence of bone marrow-derived mesenchymal stem cells on liver ischemia-reperfusion injury in a rat model," Annals of Transplantation, vol. 20, pp. 132-140, 2015.
44. G.-Z. Pan, Y. Yang, J. Zhang et al.,"Bone marrow mesenchymal stem cells ameliorate hepatic ischemia/reperfusion injuries via inactivation of the MEK/ERK signaling pathway in rats," Journal of Surgical Research, vol. 178, no. 2, pp. 935-948, 2012.
45. J. Fu, H. Zhang, Y. Zhuang et al., "The role of N-acetyltransferase 8 in mesenchymal stem cell-based therapy for liver ischemia/reperfusion injury in rats," PLoS ONE, vol. 9, no. 7, Article ID e103355, 2014.